McIntosh MW - Search Results

1

Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer.

Goodell V, Salazar LG, Urban N, Drescher CW, Gray H, Swensen RE, McIntosh MW, Disis ML. Goodell V, et al. Among authors: mcintosh mw. J Clin Oncol. 2006 Feb 10;24(5):762-8. doi: 10.1200/JCO.2005.03.2813. Epub 2006 Jan 3. J Clin Oncol. 2006. PMID: 16391298

2

Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma.

McIntosh MW, Liu Y, Drescher C, Urban N, Diamandis EP. McIntosh MW, et al. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4422-8. doi: 10.1158/1078-0432.CCR-06-2224. Clin Cancer Res. 2007. PMID: 17671125

3

Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule.

Drescher CW, Shah C, Thorpe J, O'Briant K, Anderson GL, Berg CD, Urban N, McIntosh MW. Drescher CW, et al. Among authors: mcintosh mw. J Clin Oncol. 2013 Jan 20;31(3):387-92. doi: 10.1200/JCO.2012.43.6691. Epub 2012 Dec 17. J Clin Oncol. 2013. PMID: 23248253 Free PMC article.

4

Ovarian Cancer Early Detection Needs Better Imaging, Not Better Algorithms or Biomarkers.

McIntosh MW, Drescher C, Fitzgibbon MM. McIntosh MW, et al. J Clin Oncol. 2016 Jan 10;34(2):199-200. doi: 10.1200/JCO.2015.63.7843. Epub 2015 Nov 16. J Clin Oncol. 2016. PMID: 26573076 No abstract available.

5

Changes in cancer worry associated with participation in ovarian cancer screening.

Andersen MR, Drescher CW, Zheng Y, Bowen DJ, Wilson S, Young A, McIntosh M, Mahony BS, Lowe KA, Urban N. Andersen MR, et al. Psychooncology. 2007 Sep;16(9):814-20. doi: 10.1002/pon.1151. Psychooncology. 2007. PMID: 17225260 Clinical Trial.

6

Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.

Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh M, Andersen MR, Scholler N, Bergan L, Thorpe J, Urban N, Drescher CW. Lowe KA, et al. Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2480-7. doi: 10.1158/1055-9965.EPI-08-0150. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18768519 Free PMC article.

7

Integrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancer.

Amon LM, Law W, Fitzgibbon MP, Gross JA, O'Briant K, Peterson A, Drescher C, Martin DB, McIntosh M. Amon LM, et al. PLoS One. 2010 Jun 15;5(6):e11137. doi: 10.1371/journal.pone.0011137. PLoS One. 2010. PMID: 20559444 Free PMC article.

8

Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening.

Drescher CW, Hawley S, Thorpe JD, Marticke S, McIntosh M, Gambhir SS, Urban N. Drescher CW, et al. Cancer Prev Res (Phila). 2012 Aug;5(8):1015-24. doi: 10.1158/1940-6207.CAPR-11-0468. Epub 2012 Jul 2. Cancer Prev Res (Phila). 2012. PMID: 22750949 Free PMC article.

9

Generating longitudinal screening algorithms using novel biomarkers for disease.

McIntosh MW, Urban N, Karlan B. McIntosh MW, et al. Cancer Epidemiol Biomarkers Prev. 2002 Feb;11(2):159-66. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11867503

10

Ovarian cancer screening.

Urban N, McIntosh MW, Andersen M, Karlan BY. Urban N, et al. Among authors: mcintosh mw. Hematol Oncol Clin North Am. 2003 Aug;17(4):989-1005, ix. doi: 10.1016/s0889-8588(03)00063-7. Hematol Oncol Clin North Am. 2003. PMID: 12959188 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters